Relmada Therapeutics Inc RLMD Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc (RLMD) Financials

Relmada Therapeutics Inc (RLMD)

2.90

0.18

(6.62%)

Closed November 29 3:00PM

Delayed by 15 minutes

2.889

-0.011

(-0.38%)

After Hours: 6:59PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2017	2018	2019	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-443.215	-304.537	-261.049	-12.873	-50.532	-73.644	-83.483	-78.889
Return on Equity (%)	-861.233	442.191	-1649.333	-13.297	-53.743	-80.136	-90.074	-87.507
Return on Invested Capital (%)	-1312.545	293.653	-1617.281	-13.464	-55.068	-80.141	-92.502	-91.888
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.117	-0.439	0.195	8.002	6.464	7.508	4.666	2.836
Earnings Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
Cash Per Share	0.137	0.178	0.236	2.509	0.153	1.602	0.179	0.136
Working Capital Per Share	0.088	-0.252	0.189	7.988	6.458	7.507	4.665	2.834
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
EBITDA Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
Free Cash Flow Per Share	-0.498	-0.713	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282

Liquidity Ratios

Year End December 30 2023	2017	2018	2019	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	12.53M	12.55M	38.98M	14.46M	16.33M	27.74M	30.1M	N/A

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	30.03M	28.64M	30.1M	N/A	N/A	30.1M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	82.07M
Price to Earnings Ratio	-0.88
Price to Sales Ratio	0
Price to Cash Ratio	21.31
Price to Book Ratio	1.02
Dividend Yield	-

Share Statistics

Shares Outstanding	30.17M
Average Volume (1 week)	164.43k
Average Volume (1 Month)	126.47k
52 Week Change	0.69%
52 Week High	7.2225
52 Week Low	1.88

More Ratios Coming Soon!

Relmada Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions